Abstract
The controversial concept of a “mesenchymal stem cell”, also known as “multipotent stromal cell” or “MSC”, has served as a cell biological foundation upon which to build and test hypotheses examining the complex relationships between bone, fat and skeletal muscle. Multiple independent studies have demonstrated the presence of MSC-like cells within connective tissues including bone, fascia, fat, marrow, skeletal muscle, and tendon. The MSC has been defined based on its plastic adherence and proliferative properties in vitro, its trilineage (adipogenic, chondrogenic, and osteogenic) differentiation ability, and its distinctive surface immunophenotype. Moreover, the differentiated MSC adipocytes, myocytes and osteoblasts secrete distinct profiles of growth factors termed “adipokines”, “myokines” and “osteokines”. These “-kines”, which include both anti- and pro-inflammatory cytokines, account in part for the MSC’s immunomodulatory and immunosuppressive functions in vitro and in vivo. Recent studies have focused on the MSC’s secretion of microvesicular “exosomes” containing cytokines, adhesive surface proteins, and microRNAs capable of positively or negatively modulating lineage specific signal transduction pathways. This chapter reviews the history and recent discoveries relating MSCs to the biological aging-associated pathologies of obesity, osteoporosis, and sarcopenia.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsAbbreviations
- ALK:
-
Activin-Like Receptor Kinase
- AMPK:
-
5′ Adenosine Monophosphate Activated Protein Kinase
- ASC:
-
Adipose-derived Stromal/Stem Cell
- BAT:
-
Brown Adipose Tissue
- BDNF:
-
Brain Derived Neurotrophic Factor
- BMP:
-
Bone Morphogenetic Protein
- BMSC:
-
Bone Marrow-derived Mesenchymal Stem Cell or Bone Marrow-derived Multipotent Stromal Cell
- C/EBP:
-
CCAAT Enhancer Binding Protein
- ER:
-
Estrogen Receptor
- FDNC5:
-
Fibronectin Domain Containing Protein 5
- FGF:
-
Fibroblast Growth Factor
- GDF:
-
Growth and Differentiation Factor
- GR:
-
Glucocorticoid Receptor
- HLH:
-
Helix Loop Helix
- IFATS:
-
International Federation for Adipose Therapeutics and Science
- IGF-1:
-
Insulin like Growth Factor 1
- IL:
-
Interleukine
- IMAT:
-
Intramuscular Adipose Tissue
- ISCT:
-
International Society for Cell & Gene Therapy
- M-CSF:
-
Macrophage Colony Stimulating Factor
- MEF:
-
Myocyte Enhancer Factor
- miRNA:
-
Micro RNA
- MSC:
-
Mesenchymal Stem Cell or Multipotent Stromal Cell
- NFκB:
-
Nuclear Factor κ Light Chain Enhancer of Activated B Cells
- NHR:
-
Nuclear Hormone Receptor
- OCN:
-
Osteocalcin
- PAI-1:
-
Plasminogen Activator Inhibitor 1
- PEDF:
-
Pigment Epithelium Derived Factor
- PGC1:
-
PPARγ Co-Activator 1
- PPARγ:
-
Peroxisome Proliferator Activated Receptor γ
- RANKL:
-
Receptor Activator for Nuclear Factor κ B Ligand
- RUNX2:
-
Runt Related Transcription Factor 2
- SMAD:
-
Small worm phenotype Mothers Against Decapentaplegic (BMP Transcription Factors)
- SMSC:
-
Skeletal Muscle Stem Cell
- SVF:
-
Stromal Vascular Fraction
- TGFβ:
-
Transforming Growth Factor β
- TNFα:
-
Tumor Necrosis Factor α
- TRAP:
-
Tartrate Resistant Acid Phosphatase
- VDR:
-
Vitamin D Receptor
- WAT:
-
White Adipose Tissue
References
Allen TD, Dexter TM (1976) Cellular interrelationships during in vitro granulopoiesis. Diff Res Biol Diver 6:191–194
Ashton BA, Allen TD, Howlett CR, Eaglesom CC, Hattori A, Owen M (1980) Formation of bone and cartilage by marrow stromal cells in diffusion chambers in vivo. Clin Orthopaed Relat Res 151:294–307
Becker C, Lord SR, Studenski SA, Warden SJ, Fielding RA, Recknor CP, Hochberg MC, Ferrari SL, Blain H, Binder EF, Rolland Y, Poiraudeau S, Benson CT, Myers SL, Hu L, Ahmad QI, Pacuch KR, Gomez EV, Benichou O, S. Group (2015) Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. Lancet Diabetes Endocrinol 3:948–957
Beresford JN, Bennett JH, Devlin C, Leboy PS, Owen ME (1992) Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J Cell Sci 102(Pt 2):341–351
Bostrom P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Bostrom EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Hojlund K, Gygi SP, Spiegelman BM (2012) A PGC1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481:463–468
Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15:641–648
Braun T, Buschhausen-Denker G, Bober E, Tannich E, Arnold HH (1989) A novel human muscle factor related to but distinct from MyoD1 induces myogenic conversion in 10T1/2 fibroblasts. EMBO J 8:701–709
Buehring B, Binkley N (2013) Myostatin--the holy grail for muscle, bone, and fat? Curr Osteoporos Rep 11:407–414
Campbell C, McMillan HJ, Mah JK, Tarnopolsky M, Selby K, McClure T, Wilson DM, Sherman ML, Escolar D, Attie KM (2017) Myostatin inhibitor ACE-031 treatment of ambulatory boys with Duchenne muscular dystrophy: Results of a randomized, placebo-controlled clinical trial. Muscle Nerve 55:458–464
Caplan AI (1991) Mesenchymal stem cells. J Orthop Res 9:641–650
Caplan AI, Correa D (2011) The MSC: an injury drugstore. Cell Stem Cell 9:11–15
Chen L, Holmstrom K, Qiu W, Ditzel N, Shi K, Hokland L, Kassem M (2014) MicroRNA-34a inhibits osteoblast differentiation and in vivo bone formation of human stromal stem cells. Stem Cells 32:902–912
Choi HY, Kim S, Park JW, Lee NS, Hwang SY, Huh JY, Hong HC, Yoo HJ, Baik SH, Youn BS, Mantzoros CS, Choi KM (2014) Implication of circulating irisin levels with brown adipose tissue and sarcopenia in humans. J Clin Endocrinol Metab 99:2778–2785
Clark EA, Kalomoiris S, Nolta JA, Fierro FA (2014) Concise review: MicroRNA function in multipotent mesenchymal stromal cells. Stem Cells 32:1074–1082
Colaianni G, Mongelli T, Colucci S, Cinti S, Grano M (2016) Crosstalk Between Muscle and Bone Via the Muscle-Myokine Irisin. Curr Osteoporos Rep 14:132–137
D’Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA (1999) Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res 14:1115–1122
Dennison EM, Sayer AA, Cooper C (2017) Epidemiology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatol 13:340–347
Dexter TM, Allen TD, Lajtha LG (1977) Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91:335–344
Dominici M, Le Blanc K, Mueller I, Slaper-Cortenbach I, Marini F, Krause D, Deans R, Keating A, Prockop D, Horwitz E (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315–317
Ducy P, Karsenty G (1995) Two distinct osteoblast-specific cis-acting elements control expression of a mouse osteocalcin gene. Mol Cell Biol 15:1858–1869
Ducy P, Amling M, Takeda S, Priemel M, Schilling AF, Beil FT, Shen J, Vinson C, Rueger JM, Karsenty G (2000) Leptin inhibits bone formation through a hypothalamic relay: a central control of bone mass. Cell 100:197–207
Elkasrawy MN, Hamrick MW (2010) Myostatin (GDF-8) as a key factor linking muscle mass and bone structure. J Musculoskelet Neuronal Interact 10:56–63
Emont MP, Yu H, Wu J (2015) Transcriptional control and hormonal response of thermogenic fat. J Endocrinol 225:R35–R47
Eskildsen T, Taipaleenmaki H, Stenvang J, Abdallah BM, Ditzel N, Nossent AY, Bak M, Kauppinen S, Kassem M (2011) MicroRNA-138 regulates osteogenic differentiation of human stromal (mesenchymal) stem cells in vivo. Proc Natl Acad Sci U S A 108:6139–6144
Friedenstein AJ (1976) Precursor cells of mechanocytes. Int Rev Cytol 47:327–359
Friedenstein AJ, Lalykina KS (1972) Thymus cells are inducible to osteogenesis. Eur J Immunol 2:602–603
Friedenstein AJ, Petrakova KV, Kurolesova AI, Frolova GP (1968) Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation 6:230–247
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 3:393–403
Galipeau J, Krampera M (2015) The challenge of defining mesenchymal stromal cell potency assays and their potential use as release criteria. Cytotherapy 17:125–127
Galipeau J, Krampera M, Barrett J, Dazzi F, Deans RJ, DeBruijn J, Dominici M, Fibbe WE, Gee AP, Gimble JM, Hematti P, Koh MB, LeBlanc K, Martin I, McNiece IK, Mendicino M, Oh S, Ortiz L, Phinney DG, Planat V, Shi Y, Stroncek DF, Viswanathan S, Weiss DJ, Sensebe L (2016) International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials. Cytotherapy 18:151–159
Geoffroy V, Ducy P, Karsenty G (1995) A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element. J Biol Chem 270:30973–30979
Gimble JM (1990) The function of adipocytes in the bone marrow stroma. New Biol 2:304–312
Gimble JM, Nuttall ME (2004) Bone and fat: old questions, new insights. Endocrine 23:183–188
Green H, Kehinde O (1975) An established preadipose cell line and its differentiation in culture. II. Factors affecting the adipose conversion. Cell 5:19–27
Grigoriadis AE, Heersche JN, Aubin JE (1988) Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone. J Cell Biol 106:2139–2151
Hamrick MW (2017) Role of the Cytokine-like Hormone Leptin in Muscle-bone Crosstalk with Aging. J Bone Metab 24:1–8
Hamrick MW, Della-Fera MA, Choi YH, Pennington C, Hartzell D, Baile CA (2005) Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob/ob mice. J Bone Miner Res 20:994–1001
Hamrick MW, Ding KH, Pennington C, Chao YJ, Wu YD, Howard B, Immel D, Borlongan C, McNeil PL, Bollag WB, Curl WW, Yu J, Isales CM (2006) Age-related loss of muscle mass and bone strength in mice is associated with a decline in physical activity and serum leptin. Bone 39:845–853
Hamrick MW, McGee-Lawrence ME, Frechette DM (2016) Fatty Infiltration of Skeletal Muscle: Mechanisms and Comparisons with Bone Marrow Adiposity. Front Endocrinol (Lausanne) 7:69
Harms M, Seale P (2013) Brown and beige fat: development, function and therapeutic potential. Nat Med 19:1252–1263
Hassan MQ, Tye CE, Stein GS, Lian JB (2015) Non-coding RNAs: Epigenetic regulators of bone development and homeostasis. Bone 81:746–756
Hodges WM, O’Brien F, Fulzele S, Hamrick MW (2017) Function of microRNAs in the osteogenic differentiation and therapeutic application of adipose-derived stem cells (ASCs). Intl J Mol Sci 18:pii: E2597
Ilich JZ, Kelly OJ, Inglis JE, Panton LB, Duque G, Ormsbee MJ (2014) Interrelationship among muscle, fat, and bone: connecting the dots on cellular, hormonal, and whole body levels. Ageing Res Rev 15:51–60
Kaji H (2016) Effects of myokines on bone. Bonekey Rep 5:826
Kalinkovich A, Livshits G (2017) Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev 35:200–221
Kim KM, Lim SK (2014) Role of miRNAs in bone and their potential as therapeutic targets. Curr Opin Pharmacol 16:133–141
Kupcova Skalnikova H (2013) Proteomic techniques for characterisation of mesenchymal stem cell secretome. Biochimie 95:2196–2211
Langer R, Vacanti JP (1993) Tissue engineering. Science 260:920–926
Lanotte M, Scott D, Dexter TM, Allen TD (1982) Clonal preadipocyte cell lines with different phenotypes derived from murine marrow stroma: factors influencing growth and adipogenesis in vitro. J Cell Physiol 111:177–186
Lassar AB, Paterson BM, Weintraub H (1986) Transfection of a DNA locus that mediates the conversion of 10T1/2 fibroblasts to myoblasts. Cell 47:649–656
Li B (2018) MicroRNA Regulation in Osteogenic and Adipogenic Differentiation of Bone Mesenchymal Stem Cells and its Application in Bone Regeneration. Curr Stem Cell Res Ther 13:26–30
Ma Y, Li X, Zhang H, Ou Y, Zhang Z, Li S, Wu F, Sheng Z, Liao E (2016) Serum myostatin in central south Chinese postmenopausal women: Relationship with body composition, lipids and bone mineral density. Endocr Res 41:223–228
Martin EC, Qureshi AT, Dasa V, Freitas MA, Gimble JM, Davis TA (2016) MicroRNA regulation of stem cell differentiation and diseases of the bone and adipose tissue: Perspectives on miRNA biogenesis and cellular transcriptome. Biochimie 124:98–111
Maumus M, Jorgensen C, Noel D (2013) Mesenchymal stem cells in regenerative medicine applied to rheumatic diseases: role of secretome and exosomes. Biochimie 95:2229–2234
McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O’Malley BW (1987) Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 235:1214–1217
Merriman HL, van Wijnen AJ, Hiebert S, Bidwell JP, Fey E, Lian J, Stein J, Stein GS (1995) The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry 34:13125–13132
Meunier P, Aaron J, Edouard C, Vignon G (1971) Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin Orthop Relat Res 80:147–154
Owen M (1988) Marrow stromal stem cells. J Cell Sci Suppl 10:63–76
Owen M, Friedenstein AJ (1988) Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp 136:42–60
Pal China S, Sanyal S, Chattopadhyay N (2018) Adiponectin signaling and its role in bone metabolism. Cytokine 112:116–131
Pandey AC, Semon JA, Kaushal D, O’Sullivan RP, Glowacki J, Gimble JM, Bunnell BA (2011) MicroRNA profiling reveals age-dependent differential expression of nuclear factor kappaB and mitogen-activated protein kinase in adipose and bone marrow-derived human mesenchymal stem cells. Stem Cell Res Ther 2:49
Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8:457–465
Pratesi A, Tarantini F, Di Bari M (2013) Skeletal muscle: an endocrine organ. Clin Cases Miner Bone Metab 10:11–14
Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM (1998) A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 92:829–839
Reznikoff CA, Bertram JS, Brankow DW, Heidelberger C (1973a) Quantitative and qualitative studies of chemical transformation of cloned C3H mouse embryo cells sensitive to postconfluence inhibition of cell division. Cancer Res 33:3239–3249
Reznikoff CA, Brankow DW, Heidelberger C (1973b) Establishment and characterization of a cloned line of C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33:3231–3238
Ribeiro CA, Fraga JS, Graos M, Neves NM, Reis RL, Gimble JM, Sousa N, Salgado AJ (2012) The secretome of stem cells isolated from the adipose tissue and Wharton jelly acts differently on central nervous system derived cell populations. Stem Cell Res Ther 3:18
Ruckle J, Jacobs M, Kramer W, Pearsall AE, Kumar R, Underwood KW, Seehra J, Yang Y, Condon CH, Sherman ML (2009) Single-dose, randomized, double-blind, placebo-controlled study of ACE-011 (ActRIIA-IgG1) in postmenopausal women. J Bone Miner Res 24:744–752
Rudnicki MA, Williams BO (2015) Wnt signaling in bone and muscle. Bone 80:60–66
Salgado AJ, Gimble JM (2013) Secretome of mesenchymal stem/stromal cells in regenerative medicine. Biochimie 95:2195
Salgado AJ, Reis RL, Sousa NJ, Gimble JM (2010) Adipose tissue derived stem cells secretome: soluble factors and their roles in regenerative medicine. Curr Stem Cell Res Ther 5:103–110
Scimeca JC, Verron E (2017) The multiple therapeutic applications of miRNAs for bone regenerative medicine. Drug Discov Today 22:1084–1091
Tagliaferri C, Wittrant Y, Davicco MJ, Walrand S, Coxam V (2015) Muscle and bone, two interconnected tissues. Ageing Res Rev 21:55–70
Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G (2002) Leptin regulates bone formation via the sympathetic nervous system. Cell 111:305–317
Tapscott SJ, Davis RL, Thayer MJ, Cheng PF, Weintraub H, Lassar AB (1988) MyoD1: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 242:405–411
Taylor SM, Jones PA (1979) Multiple new phenotypes induced in 10T1/2 and 3T3 cells treated with 5-azacytidine. Cell 17:771–779
Teixeira FG, Carvalho MM, Sousa N, Salgado AJ (2013) Mesenchymal stem cells secretome: a new paradigm for central nervous system regeneration? Cell Mol Life Sci CMLS 70:3871–3882
Teixeira FG, Carvalho MM, Neves-Carvalho A, Panchalingam KM, Behie LA, Pinto L, Sousa N, Salgado AJ (2015) Secretome of mesenchymal progenitors from the umbilical cord acts as modulator of neural/glial proliferation and differentiation. Stem Cell Rev 11:288–297
Tontonoz P, Hu E, Graves RA, Budavari AI, Spiegelman BM (1994) mPPAR gamma 2: tissue-specific regulator of an adipocyte enhancer. Genes Dev 8:1224–1234
Tseng YH, Kokkotou E, Schulz TJ, Huang TL, Winnay JN, Taniguchi CM, Tran TT, Suzuki R, Espinoza DO, Yamamoto Y, Ahrens MJ, Dudley AT, Norris AW, Kulkarni RN, Kahn CR (2008) New role of bone morphogenetic protein 7 in brown adipogenesis and energy expenditure. Nature 454:1000–1004
Umek RM, Friedman AD, McKnight SL (1991) CCAAT-enhancer binding protein: a component of a differentiation switch. Science 251:288–292
van der Eerden BC (2014) MicroRNAs in the skeleton: cell-restricted or potent intercellular communicators? Arch Biochem Biophys 561:46–55
Wei J, Karsenty G (2015) An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord 16:93–98
Wei J, Ferron M, Clarke CJ, Hannun YA, Jiang H, Blaner WS, Karsenty G (2014) Bone-specific insulin resistance disrupts whole-body glucose homeostasis via decreased osteocalcin activation. J Clin Invest 124:1–13
Weinberger C, Hollenberg SM, Ong ES, Harmon JM, Brower ST, Cidlowski J, Thompson EB, Rosenfeld MG, Evans RM (1985) Identification of human glucocorticoid receptor complementary DNA clones by epitope selection. Science 228:740–742
Wright WE, Sassoon DA, Lin VK (1989) Myogenin, a factor regulating myogenesis, has a domain homologous to MyoD. Cell 56:607–617
Wu Y, Qu J, Li H, Yuan H, Guo Q, Ouyang Z, Lu Q (2018) Relationship between serum level of GDF8, GDF11 and bone mineral density in girls with anorexia nervosa. Clin Endocrinol 90(1):88–93
Yin H, Price F, Rudnicki MA (2013) Satellite cells and the muscle stem cell niche. Physiol Rev 93:23–67
Young HE, Ceballos EM, Smith JC, Mancini ML, Wright RP, Ragan BL, Bushell I, Lucas PA (1993) Pluripotent mesenchymal stem cells reside within avian connective tissue matrices. In Vitro Cell Dev Biol Anim 29A:723–736
Zaragosi LE, Wdziekonski B, Villageois P, Keophiphath M, Maumus M, Tchkonia T, Bourlier V, Mohsen-Kanson T, Ladoux A, Elabd C, Scheideler M, Trajanoski Z, Takashima Y, Amri EZ, Lacasa D, Sengenes C, Ailhaud G, Clement K, Bouloumie A, Kirkland JL, Dani C (2010) Activin a plays a critical role in proliferation and differentiation of human adipose progenitors. Diabetes 59:2513–2521
Zvonic S, Lefevre M, Kilroy G, Floyd ZE, DeLany JP, Kheterpal I, Gravois A, Dow R, White A, Wu X, Gimble JM (2007) Secretome of primary cultures of human adipose-derived stem cells: modulation of serpins by adipogenesis. Mol Cell Proteom MCP 6:18–28
Acknowledgements and Disclosures
The author wishes to thank Ms. Andrea Alarcon and Dr. Xiying Wu (LaCell LLC) and Dr. Trivia Frazier (Obatala Sciences) for their discussion and critical review of this manuscript during its preparation. The author is the co-owner, co-founder, and Chief Scientific Officer of LaCell LLC, a for profit biotechnology company focusing on stromal/stem cell therapies and investigation and the co-owner and co-founder of Obatala Sciences, Inc., a fat on a chip discovery company, and Talaria Antibodies Inc., a custom antibody production company.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Gimble, J.M. (2019). Mesenchymal Stem Cells as Regulators of Bone, Muscle, and Fat Formation. In: Duque, G. (eds) Osteosarcopenia: Bone, Muscle and Fat Interactions. Springer, Cham. https://doi.org/10.1007/978-3-030-25890-0_2
Download citation
DOI: https://doi.org/10.1007/978-3-030-25890-0_2
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-25889-4
Online ISBN: 978-3-030-25890-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)